Probiotics Show Promise in Combating Altitude Sickness, New Study Suggests

The allure of towering peaks and breathtaking vistas draws millions to high-altitude environments each year. However, for a significant portion of these adventurers, the thin air at elevated elevations presents a formidable challenge: altitude sickness. With estimates suggesting that up to 75 percent of individuals recreating above 10,000 feet experience symptoms ranging from mild discomfort to debilitating illness, the quest for effective prevention and mitigation strategies is ongoing. Now, groundbreaking research from the University of California San Diego (UCSD) School of Medicine is shedding light on a surprisingly accessible and potentially powerful ally in this fight: probiotics, the beneficial bacteria found in our gut.

Published on March 6, 2026, this new study, led by Dr. Tatum Simonson, an associate professor of medicine and the John B. West Endowed Chair in Respiratory Physiology at UCSD, proposes that bacteriotherapy – the therapeutic use of bacteria to restore gut health – could play a crucial role in enhancing the body’s resilience to the physiological stressors of high altitude. This research opens a new frontier in understanding how our internal microbial ecosystem influences our ability to thrive in environments with reduced oxygen availability.

The study involved 17 participants who were subjected to rigorous testing at UCSD’s White Mountain Research Station, situated at a challenging elevation of 12,470 feet. The experimental design was meticulously crafted as a randomized, double-blind, placebo-controlled trial, the gold standard for ensuring scientific validity and minimizing bias. This means that neither the participants nor the researchers administering the treatments knew who was receiving the active probiotic supplement and who was receiving a placebo. Over the course of the study, researchers meticulously monitored various physiological parameters, including breathing patterns, sleep quality, and overall participant well-being. Beyond these qualitative assessments, critical secondary data such as resting heart rate, blood pressure, and fasting glucose levels were also collected and analyzed.

The findings of this meticulously designed study were compelling. Participants who consistently took probiotics demonstrated significantly higher levels of oxygen saturation in their blood, both during the daytime and throughout the night, while at high altitude. This measurable improvement in oxygenation is a critical indicator of the body’s ability to cope with reduced atmospheric oxygen.

Dr. Simonson elaborated on the significance of these results in an interview with Backpacker magazine, stating, "One key takeaway is that probiotic use was associated with increased oxygen availability and fewer symptoms of acute mountain sickness." She further emphasized the broader implications of this discovery: "This suggests that the microbiome may play a role in how the body adapts to low-oxygen environments. If microbial communities influence processes such as breathing patterns, circulation, or oxygen regulation, they could represent an important and previously underappreciated factor in altitude tolerance."

Acute mountain sickness (AMS) arises when the body’s intricate physiological mechanisms fail to acclimatize effectively to a less oxygen-rich environment. The symptoms of AMS can manifest in various ways, from the common headache and nausea to more severe presentations like vomiting, dizziness, and fatigue. While the most straightforward and often recommended treatment for AMS is immediate descent to a lower altitude, Dr. Simonson’s team’s research offers a tantalizing glimpse into the possibility of preventing these debilitating symptoms from developing in the first place, by bolstering the body’s internal defenses.

The precise biological mechanisms by which probiotics might enhance oxygen availability and reduce AMS symptoms are still under active investigation, but Dr. Simonson has outlined several promising hypotheses. "One possibility involves signaling pathways that connect the gut to other organs, particularly the brain and lungs," she explained. The gut microbiome is a dynamic ecosystem that produces a vast array of metabolites and signaling molecules. These biochemical messengers are known to influence a wide range of bodily functions, including neural pathways, immune responses, and metabolic regulation. Dr. Simonson suggests that these signals originating from the gut could potentially impact how our bodies perceive and respond to oxygen levels, thereby modulating breathing rate and circulatory adjustments crucial for maintaining adequate oxygen supply to tissues.

"The relationship between microbes, metabolism, and oxygen regulation is complex, and several pathways may be involved," Dr. Simonson acknowledged. She stressed the need for further in-depth research to elucidate these intricate connections. "Future studies will need to determine whether probiotics influence breathing control, oxygen transport in the blood, cellular metabolism, or some combination of these processes." Unraveling these specific pathways will be critical for developing targeted and effective probiotic interventions.

The unpredictable nature of altitude sickness has long puzzled medical professionals and adventurers alike. It is often observed that individuals with excellent physical fitness and seemingly robust health can be just as susceptible to AMS as those who are less conditioned. This variability has led researchers to explore a multitude of contributing factors. Dr. Simonson posits that differences in an individual’s gut microbiome composition might account for at least some of this observed variation in altitude tolerance. Looking ahead, she envisions a future where "microbiome-based approaches such as targeted probiotics could potentially become part of preventative strategies for people traveling to or working at high altitude." This could revolutionize how we prepare for and manage the risks associated with high-elevation travel and work.

Dr. Simonson’s work is not an isolated discovery; it builds upon a growing body of research exploring the gut-brain axis and its influence on physiological responses to environmental stressors. In 2023, a significant study led by Xue Geng, a postdoctoral fellow at the Pacific Northwest Research Institute and published in the journal Sports Medicine and Health Science, highlighted the detrimental impact of extreme temperatures and hypoxia on gut bacteria. The study further indicated that strenuous physical activities like hiking and mountaineering can exacerbate this gut dysbiosis. Crucially, the research also suggested that probiotic supplementation might serve as a valuable countermeasure to mitigate these negative effects. This concurrent research strengthens the hypothesis that a healthy gut microbiome is intrinsically linked to improved performance and resilience in challenging environments.

Despite these promising findings, both Dr. Simonson and the broader scientific community emphasize that more research is needed to fully understand the potential of probiotics in managing altitude sickness. "Future research should include larger and more diverse studies to confirm how probiotics influence oxygen regulation and hypoxia tolerance and identify which individuals benefit most," Dr. Simonson urged. The current study, while groundbreaking, involved a relatively small sample size. Expanding these trials to include a greater diversity of participants in terms of age, health status, and ethnic background will be essential for generalizing the findings and ensuring the safety and efficacy of probiotic interventions across a wider population.

Ultimately, the goal is to move beyond general probiotic recommendations and develop personalized therapeutic strategies. Once the underlying biological mechanisms are fully elucidated, it may be possible to create custom probiotic formulations tailored to an individual’s specific microbiome profile, thereby maximizing their effectiveness in enhancing altitude tolerance. This could herald a new era of preventative medicine for mountain enthusiasts, enabling them to explore the world’s highest peaks with greater confidence and fewer health concerns. The journey to understanding the gut’s role in altitude sickness is ongoing, but the initial findings offer a beacon of hope for millions who dream of reaching new heights.